Matthew has over 20 years of experience in the pharmaceutical, biotechnology, and natural product industries, where he has led preclinical, clinical, and overall product development teams for some of the world’s largest R&D-based healthcare companies. He has extensive experience in the design and conduct of both qualitative and quantitative human efficacy/safety studies and has strategically recruited and managed teams of world-class scientists, including a team with two Nobel laureates, for business and product development initiatives. Matthew has considerable experience with both US and Canadian government regulators and has been instrumental in the government approval of important medicines and botanical-based products that are marketed in both countries.